{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T08:22:18Z","timestamp":1778660538544,"version":"3.51.4"},"reference-count":27,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"42","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1097\/md.0000000000005167","type":"journal-article","created":{"date-parts":[[2016,10,19]],"date-time":"2016-10-19T09:54:33Z","timestamp":1476870873000},"page":"e5167","source":"Crossref","is-referenced-by-count":15,"title":["Erdheim\u2013Chester disease (ECD)"],"prefix":"10.1097","volume":"95","author":[{"given":"Mohammad","family":"Adawi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bishara","family":"Bisharat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdalla","family":"Bowirrat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-32-20210309","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1182\/blood-2014-03-561381","article-title":"Consensus guidelines for the diagnosis and clinical management of Erdheim\u2013Chester disease","volume":"124","author":"Diamond","year":"2014","journal-title":"Blood"},{"key":"R2-32-20210309","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1097\/00005792-199605000-00005","article-title":"Erdheim\u2013Chester disease. Clinical and radiologic characteristics of 59 cases","volume":"75","author":"Veyssier-Belot","year":"1996","journal-title":"Medicine"},{"key":"R3-32-20210309","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1053\/crad.2001.0681","article-title":"Erdheim\u2013Chester disease","volume":"56","author":"Murray","year":"2001","journal-title":"Clin Radiol"},{"key":"R4-32-20210309","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/j.mayocp.2014.01.023","article-title":"Erdheim\u2013Chester disease: characteristics and management","volume":"89","author":"Munoz","year":"2014","journal-title":"Mayo Clin Proc"},{"key":"R5-32-20210309","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1097\/BOR.0b013e32834d861d","article-title":"Erdheim\u2013Chester disease","volume":"24","author":"Haroche","year":"2012","journal-title":"Curr Opin Rheumatol"},{"key":"R6-32-20210309","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1136\/annrheumdis-2012-202542","article-title":"The multifaceted clinical presentations and manifestations of Erdheim\u2013Chester disease: comprehensive review of the literature and of 10 new cases","volume":"72","author":"Cavalli","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"R7-32-20210309","first-page":"735","article-title":"Neuroradiologic aspects of Chester\u2013Erdheim disease","volume":"16","author":"Caparros-Lefebvre","year":"1995","journal-title":"AJNR Am J Neuroradiol"},{"key":"R8-32-20210309","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.2214\/ajr.183.5.1831253","article-title":"Imaging of thoracoabdominal involvement in Erdheim\u2013Chester disease","volume":"183","author":"Dion","year":"2004","journal-title":"AJR Am J Roentgenol"},{"key":"R9-32-20210309","doi-asserted-by":"crossref","first-page":"4018","DOI":"10.1002\/art.22280","article-title":"Immunohistochemical evidence of a cytokine and chemokine network in three patients with Erdheim\u2013Chester disease: implications for pathogenesis","volume":"54","author":"Stoppacciaro","year":"2006","journal-title":"Arthritis Rheum"},{"key":"R10-32-20210309","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1007\/BF01942684","article-title":"Lipoidgranulomatose","volume":"279","author":"Chester","year":"1930","journal-title":"Virchows Arch Pathol Anat"},{"key":"R11-32-20210309","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.critrevonc.2015.02.004","article-title":"Erdheim\u2013Chester disease: a systematic review","volume":"95","author":"Cives","year":"2015","journal-title":"Crit Rev Oncol Hematol"},{"key":"R12-32-20210309","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1111\/j.1600-0560.2010.01650.x","article-title":"Erdheim\u2013Chester disease presenting with cutaneous involvement: a case report and literature review","volume":"38","author":"Volpicelli","year":"2011","journal-title":"J Cutan Pathol"},{"key":"R13-32-20210309","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1186\/1750-1172-8-137","article-title":"Erdheim\u2013Chester disease: a comprehensive review of the literature","volume":"8","author":"Mazor","year":"2013","journal-title":"Orphanet J Rare Dis"},{"key":"R14-32-20210309","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/S0046-8177(99)90228-9","article-title":"Chester\u2013Erdheim disease: a neoplastic disorder","volume":"30","author":"Chetritt","year":"1999","journal-title":"Hum Pathol"},{"key":"R15-32-20210309","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.prp.2009.02.004","article-title":"Clonal status and clinicopathological feature of Erdheim\u2013Chester disease","volume":"205","author":"Gong","year":"2009","journal-title":"Pathol Res Pract"},{"key":"R16-32-20210309","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1097\/01.pas.0000213366.33627.a0","article-title":"Clonal cytogenetic abnormalities in Erdheim\u2013Chester disease","volume":"31","author":"Vencio","year":"2007","journal-title":"Am J Surg Pathol"},{"key":"R17-32-20210309","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1182\/blood-2010-04-279083","article-title":"Recurrent BRAF mutations in Langerhans cell histiocytosis","volume":"116","author":"Badalian-Very","year":"2010","journal-title":"Blood"},{"key":"R18-32-20210309","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1093\/rheumatology\/kes016","article-title":"Whole-body MRI in Erdheim\u2013Chester disease","volume":"51","author":"Arnaud","year":"2012","journal-title":"Rheumatology (Oxford"},{"key":"R19-32-20210309","doi-asserted-by":"crossref","first-page":"e33891","DOI":"10.1371\/journal.pone.0033891","article-title":"B-RAF mutant alleles associated with Langerhans cell histiocytosis, a granulomatous pediatric disease","volume":"7","author":"Satoh","year":"2012","journal-title":"PLoS One"},{"key":"R20-32-20210309","doi-asserted-by":"crossref","first-page":"e28","DOI":"10.1182\/blood-2012-06-429597","article-title":"BRAFV600E mutant protein is expressed in cells of variable maturation in Langerhans cell histiocytosis","volume":"120","author":"Sahm","year":"2012","journal-title":"Blood"},{"key":"R21-32-20210309","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1136\/annrheumdis-2013-204924","article-title":"BRAFV600E-mutation is invariably present and associated to oncogene-induced senescence in Erdheim\u2013Chester disease","volume":"74","author":"Cangi","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"R22-32-20210309","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1097\/00000441-200208000-00008","article-title":"Erdheim\u2013Chester disease with prominent pericardial involvement: clinical, radiologic, and histologic findings","volume":"324","author":"Gupta","year":"2002","journal-title":"Am J Med Sci"},{"key":"R23-32-20210309","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/1750-1172-8-72","article-title":"Management of adult patients with Langerhans cell histiocytosis: recommendations from an expert panel on behalf of Euro-Histio-Net","volume":"8","author":"Girschikofsky","year":"2013","journal-title":"Orphanet J Rare Dis"},{"key":"R24-32-20210309","doi-asserted-by":"crossref","first-page":"2778","DOI":"10.1182\/blood-2010-06-294108","article-title":"CNS involvement and treatment with interferon-alpha are independent prognostic factors in Erdheim\u2013Chester disease: a multicenter survival analysis of 53 patients","volume":"117","author":"Arnaud","year":"2011","journal-title":"Blood"},{"key":"R25-32-20210309","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1182\/blood-2012-07-446286","article-title":"Dramatic efficacy of vemurafenib in both multisystemic and refractory Erdheim\u2013Chester disease and Langerhans cell histiocytosis harboring the BRAF V600E mutation","volume":"121","author":"Haroche","year":"2013","journal-title":"Blood"},{"key":"R26-32-20210309","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1517\/21678707.2013.847785","article-title":"Strategies and treatment alternatives in the management of Erdheim\u2013Chester disease","volume":"1","author":"Mazor","year":"2013","journal-title":"Expert Opin Orphan Drugs"},{"key":"R27-32-20210309","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1586\/1744666X.2015.1060857","article-title":"The histiocytosis Erdheim\u2013Chester disease is an inflammatory myeloid neoplasm","volume":"11","author":"Haroche","year":"2015","journal-title":"Expert Rev Clin Immunol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000005167","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T02:35:50Z","timestamp":1620959750000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00005792-201610180-00032"}},"subtitle":["Case report, clinical and basic investigations, and review of literature"],"short-title":[],"issued":{"date-parts":[[2016,10]]},"references-count":27,"journal-issue":{"issue":"42","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000005167","relation":{},"ISSN":["0025-7974"],"issn-type":[{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2016,10]]}}}